Skip to content
pharmanlifescience
  • Home
  • About Us
  • Magazines
  • Articles
    • Research & Development
    • Global Health Perspectives
    • Biotechnology & Innovations
    • Healthcare & Therapeutics
    • Pharmaceutical Manufacturing
  • News
  • Contact Us
  • Home
  • About Us
  • Magazines
  • Articles
    • Research & Development
    • Global Health Perspectives
    • Biotechnology & Innovations
    • Healthcare & Therapeutics
    • Pharmaceutical Manufacturing
  • News
  • Contact Us
Subscribe
Mitochon Pharmaceuticals

Mitochon Pharmaceuticals: Channeling the Ability of Mitochondria to Create Resilient, Protective Cells in Neurodegeneration and Aging

Mitochon Pharmaceuticals was launched in November 2014 with joint seed money from Ben Franklin Technology

Read More »
Bryce Yao

Chengyang Bryce Yao: Advancing Diagnostics to Improve Patient Outcomes

In today’s world, medical technology has the power to save lives and improve patient outcomes.

Read More »
« Previous Page1 Page2 Next »
pharmanlifescience
Pharmanlifescience transcends ordinary magazines, serving as a vibrant hub for collaboration and knowledge exchange within the dynamic life sciences arena …..Read More

© 2026 PHARMANLIFESCIENCE. All Rights Reserved

Quick Links

  • Home
  • About Us
  • Magazines
  • Articles
    • Research & Development
    • Global Health Perspectives
    • Biotechnology & Innovations
    • Healthcare & Therapeutics
    • Pharmaceutical Manufacturing
  • News
  • Contact Us
  • Home
  • About Us
  • Magazines
  • Articles
    • Research & Development
    • Global Health Perspectives
    • Biotechnology & Innovations
    • Healthcare & Therapeutics
    • Pharmaceutical Manufacturing
  • News
  • Contact Us

Latest Posts

Aptamer Group wins £617,000 contract with global pharma giant

Aptamer Group wins £617,000 contract with global pharma giant

Major Pharma Companies Eye ImmuPharma’s Innovative P140 Treatment

Major Pharma Companies Eye ImmuPharma’s Innovative P140 Treatment

Alvotech and Advanz Pharma get EU approval for first Simponi biosimilar to treat immune diseases

Alvotech and Advanz Pharma get EU approval for first Simponi biosimilar to treat immune diseases

GSK Enters Myeloid Cell Engager Race with $50M LTZ Therapeutics Partnership

GSK Enters Myeloid Cell Engager Race with $50M LTZ Therapeutics Partnership